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ABSTRACT 
Objective: To develop a simple, economic and validated UV spectrophotometric method for the simultaneous estimation of aceclofenac and 
tramadol hydrochloride in bulk and tablet dosage form. 
Methods: The UV spectrophotometric method for simultaneous estimation of aceclofenac and tramadol hydrochloride has been developed. 
Methanol and water in the ratio 60:40 was used as the solvent. Tramadol hydrochloride and aceclofenac showed maximum absorbance at 
wavelength 214.8 nm and 275.6 nm respectively.  
Results: The developed method showed tramadol hydrochloride and aceclofenac to be linear in the concentration range of 5–30 µg/ml with a 
correlation coefficient of 0.998 and 0.999 respectively. The result of recovery studies for the tablet was found to be in the range of 98.125%-101.0% 
and 98.01%-98.36% for tramadol hydrochloride and aceclofenac respectively.  
Conclusion: The results show that the developed UV spectrophotometric method is simple, economical, accurate, precise and repeatable. 
Keywords: UV spectrophotometric method, Tramadol Hydrochloride, Aceclofenac, Simultaneous estimation, Tablet dosage form, Validation 
© 2016 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/) 
 
INTRODUCTION 
Tramadol is an opioid pain medication which is used for moderate to 
moderately severe pain [1]. Tramadol is chemically known as (1R, 
2R)-2-[(dimethylamino) methyl]-1-(3-methoxyphenyl) cyclohexan-
1-ol (fig. 1) [2, 3]. 
Following parenteral administration, the analgesic potency of 
tramadol is about 10% of that of morphine. Postoperative pain relief 
provided by tramadol is comparable with that of pethidine. The 
combination with a non-opioid analgesic can further improve the 
analgesic efficacy of tramadol. Tramadol may prove particularly 
useful in patients with a risk of poor cardiopulmonary function 
when non-opioid analgesics are contraindicated and after surgery of 
the upper abdomen or thorax. Tramadol is a well tolerated and 
effective agent to reduce pain resulting from trauma, labor, and 
renal or biliary colic, and also for the management of chronic pain of 
nonmalignant or malignant origin, particularly neuropathic pain. 
Tramadol appears to produce less dependence and constipation 
than equianalgesic doses of strong opioids [4]. 
 
Fig. 1: Chemical structure of tramadol hydrochloride 
 
Aceclofenac is a non-steroidal anti-inflammatory drug (NSAID) 
analog of Diclofenac [5]. It is chemically known as 2-[2-[2-(2,6-
dichloroanilino) phenyl] acetyl] oxyacetic acid (fig. 2) [6]. It is 
prescribed for the relief of inflammation and pain in ankylosing 
spondylitis, osteoarthritis and rheumatoid arthritis [7].  
It should not be given to breastfeeding mothers or people with 
porphyria, and is not recommended for children. 
 
Fig. 2: Chemical structure of aceclofenac 
 
The literature survey revealed that many analytical methods like UV 
spectrophotometry [8-14], Visible spectrometry [15-22], Spectro 
fluorimetry [23], HPTLC [24-26], UPLC [27], HPLC [28-31], GC-MS 
[32] and Cyclic Voltammetry [33] were reported for the estimation 
of tramadol hydrochloride and methods like UV spectrometry [34-
42], HPLC [43-45] and HPTLC [46-48] were reported for the 
estimation of aceclofenac in bulk drug and pharmaceutical dosage 
form. However, only one UV method was reported for the estimation 
of aceclofenac and tramadol hydrochloride in combined dosage form 
by Second order Derivative Method [49]. Hence, we here report a 
new, simple and economical method for the simultaneous estimation 
of aceclofenac and tramadol hydrochloride by using Simultaneous 
Equation method [50]. 
MATERIALS AND METHODS 
Materials  
Instrument 
A UV-visible spectrophotometer (Shimadzu, Model No: 1800) with 1 
cm light path and loaded with UV probe software (version 2.43) was 
used for recording of spectra and measurement of absorbance. An 
electronic weighing balance (1 mg sensitivity, Contech CA 123) and a 
sonicator (Expo-Hi-tech, Sr. No. 2K810011) were used. 
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Chemicals and reagents 
Analytically pure sample of tramadol hydrochloride and aceclofenac 
were obtained from Yarrow Chem, Mumbai, India and the tablet 
formulation (TAXIDOL) was purchased from local markets with 
labeled amount 37.5 mg of tramadol hydrochloride and 100 mg of 




A solvent used was prepared by adding methanol and water in the 
ration of 60:40. 
Selection of suitable wavelength for detection 
Suitable wavelength was obtained by recording UV spectra in the 
range of 200–400 nm for tramadol hydrochloride and aceclofenac 
respectively. The wavelength of maximum absorbance for tramadol 
hydrochloride and aceclofenac was found to be 214.8 nm and 275.6 
nm respectively. 
Preparation of stock and working standard solution 
100 mg of tramadol hydrochloride working standard and 100 mg of 
aceclofenac working standard were weighed accurately in a 100 ml 
volumetric flask respectively. 80 ml of solvent was added, sonicated 
to dissolve and diluted to volume with the solvent. Further, 1 ml of 
this solution was diluted to 10 ml, respectively with the solvent. 
Then, 0.94 ml of tramadol hydrochloride and 2.5 ml of aceclofenac 
solution were diluted to 10 ml, respectively, with the solvent to get a 
final concentration of 9.4 µg/ml and 25 µg/ml respectively.  
Preparation of stock and working sample solution 
20 tablets were weighed and powdered. The quantity of powder 
containing the equivalent of about 37.5 mg of tramadol 
hydrochloride and 100 mg of aceclofenac was weighed accurately 
into a 100 ml volumetric flask. 50 ml of the solvent was added, 
sonicated for 20 min with intermediate shaking, diluted up to the 
mark with the solvent and mixed, and filtered through 0.45 µ PVDF 
filter. Further, 1 ml of this solution was diluted to 10 ml with the 
solvent. Then, 2.5 ml of this solution was diluted to 10 ml with the 
solvent to get a final concentration of 9.4 µg/ml and 25 µg/ml for 
tramadol hydrochloride and aceclofenac respectively. 
Validation of methods [51] 
Method validation is the process used to confirm that the analytical 
procedure employed for a specific test is suitable for its intended 
use. Results from method validation can be used to evaluate the 
quality, consistency, and reliability of analytical results.  
The method was validated for parameters like accuracy, linearity, 
interday precision, intraday precision, robustness, ruggedness, limit 
of detection (LOD) and limit of quantification (LOQ). 
Linearity 
The linearity of tramadol hydrochloride and aceclofenac was 
performed by using the standard solutions in the concentration 
range of 5–30 µg/ml. Calibration curve was acquired by plotting 
concentration versus absorbance at 214.8 nm for tramadol 
hydrochloride and at 275.6 nm for aceclofenac. The correlation 
coefficients were greater than 0.995. 
Intraday precision 
Six similar recordings of absorbance at 214.8 nm and 275.6 nm of a 
standard solution of tramadol hydrochloride and aceclofenac 
respectively at working concentration were obtained on the same 
day. The results showed % Relative Standard Deviation (% RSD) less 
than 2%. 
Interday precision 
Six similar recordings of absorbance at 214.8 nm and 275.6 nm of a 
standard solution of tramadol hydrochloride and aceclofenac 
respectively at working concentration were obtained on three 
consecutive days. The results showed % RSD less than 2%. 
Accuracy 
Three different determinations of absorbance at three different 
levels (80%, 100% and 120%) of a standard solution of tramadol 
hydrochloride and aceclofenac respectively at 214.8 nm and 275.6 
nm were performed. Similarly, three different determinations of 
absorbance at three different levels (80%, 100% and 120%) of a 
sample solution containing both tramadol hydrochloride and 
aceclofenac at 214.8 nm and 275.6 nm were performed. The 
concentration of tramadol hydrochloride and aceclofenac in the 
sample solution was determined by substituting the absorbance 










Cx = concentration of Tramadol Hydrochloride A1 = absorbance of 
samples at 214.8 nm 
Cy = concentration of Aceclofenac A2 = absorbance of samples at 
275.6 nm 
The experiment was repeated thrice. 
Robustness 
Robustness of the method was evaluated by changing the 
wavelength by±2 nm. % RSD obtained was less than 2%. 
Ruggedness 
The ruggedness of the method was verified by analyzing six times 
the standard solution of tramadol hydrochloride and aceclofenac at 
working concentrations by a different analyst using different 
instruments, but operational and environmental conditions were 
maintained the same. From the results obtained, % RSD was found 
to be less than 2%. 
Limit of detection (LOD) and Limit of quantification (LOQ) 
The LOD and LOQ were calculated based on the calibration curves 
using the following formula. 
LOD = 3.3 ×  
σ
S




Where, σ = y-intercept S = slope of the regression line 
RESULTS AND DISCUSSION 
A simple, economical, precise and accurate method has been 
proposed in the article, for simultaneous estimation of tramadol 
hydrochloride and aceclofenac in bulk and tablet dosage form. 
Tramadol hydrochloride and aceclofenac showed maximum 
absorbance at wavelength 214.8 nm and 275.6 nm respectively. 
Hence, it was selected as the wavelength suitable for detection (fig. 
3). The developed method was used for the simultaneous estimation 
of tramadol hydrochloride and aceclofenac in bulk and tablet dosage 
form. Solution stability was performed at different intervals using 
the same solution, and it was found that the solution is stable up to 7 
h. Tramadol hydrochloride and aceclofenac were found to be linear 
in the concentration range of 5–30 µg/ml with a correlation 
coefficient of 0.998 and 0.999 respectively, the Beer’s law was 
obeyed (table 1) (fig. 4 and 5). % Recovery study was performed in 
order to check the accuracy of the method, at three different 
concentrations (80%, 100% and 120%) of the standard drugs.  
The result of recovery studies for the tablet was found to be in the 
range of 98.125%-101.0% and 98.01%-98.36% for tramadol 
hydrochloride and aceclofenac respectively (table 2). % RSD for 
intraday and interday precision were found to be less than 2%, 
which shows that the method is precise (table 3, 4, 5, 6). The LOD for 
tramadol hydrochloride and aceclofenac was found to be 2.412 
µg/ml and 0.244 µg/ml respectively. The LOQ for tramadol 
hydrochloride and aceclofenac was found to be 7.308 µg/ml and 
0.741 µg/ml respectively. The values showed that the method is 
sensitive and thus can be used for the determination of drugs, even 
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with lower concentrations (table 7). Robustness and ruggedness of 
the method were checked, and the % RSD was found to be less than 
2%, which indicate that the method can be suitably used for 
estimation of tramadol hydrochloride and aceclofenac in 
combination and parameters like difference in days, instruments or 
analyst won’t affect them (table 8, 9, 10). Optical characteristics and 
validation parameters of tramadol hydrochloride and aceclofenac 
are shown in table 11. 
 
 
Fig. 3: Overlain spectra of tramadol hydrochloride (9.4 µg/ml) and aceclofenac (25 µg/ml) in the solvent 
 
Table 1: Calibration data for tramadol hydrochloride and aceclofenac 
S. No. Concentration (µg/ml) Absorbance of tramadol hydrochloride at 214.8 nm Absorbance of aceclofenac at 275.6 nm 
1 5 0.1645 0.1365 
2 10 0.2974 0.2727 
3 15 0.4082 0.4040 
4 20 0.5588 0.5296 
5 25 0.6783 0.6930 
6 30 0.8028 0.8222 
 
 
Fig. 4: Calibration curve of tramadol hydrochloride at 214.8 nm 
 
Fig. 5: Calibration curve of aceclofenac at 275.6 nm
 
Table 2: Result of accuracy for tramadol hydrochloride and aceclofenac 
Concentration level % Mean recovery of tramadol hydrochloride (n=3) % Mean recovery of aceclofenac (n=3) 
80% 99.95% 98.01% 
100% 101.0% 98.36% 
120% 98.125% 98.17% 
 
Table 3: Results for intraday precision of tramadol hydrochloride 
S. No. Concentration Absorbance at 214.8 nm 
1  0.3148 
2  0.3147 
3  0.3147 
4 9.4 µg/ml 0.3148 
5  0.3148 
6  0.3146 
Mean*  0.314733 
SD**  0.00008 
% RSD***  0.025 
* mean of six determinations ** standard deviation *** % relative standard deviation 
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Table 4: Results for intraday precision of aceclofenac 
S. No. Concentration Absorbance at 275.6 nm 
1  0.6930 
2  0.6930 
3  0.6929 
4 25 µg/ml 0.6928 
5  0.6929 
6  0.6927 
Mean*  0.692883 
SD**  0.000117 
% RSD***  0.0169 
* mean of six determinations ** standard deviation *** % relative standard deviation 
 
Table 5: Results for interday precision of tramadol hydrochloride 
S. No. Concentration Absorbance at 214.8 nm 
Day 1 Day 2 Day 3 
1  0.3148 0.3146 0.3147 
2  0.3148 0.3146 0.3146 
3  0.3147 0.3144 0.3148 
4 9.4 µg/ml 0.3146 0.3145 0.3147 
5  0.3147 0.3145 0.3145 
6  0.3145 0.3144 0.3147 
Mean*  0.314683 0.3145 0.31467 
SD**  0.000117 0.00008 0.00010328 
%RSD***  0.037 0.025 0.033 
* mean of six determinations ** standard deviation *** % relative standard deviation 
 
Table 6: Results for interday precision of aceclofenac 
S. No. Concentration Absorbance at 275.6 nm 
Day 1 Day 2 Day 3 
1  0.6930 0.6927 0.6925 
2  0.6929 0.6928 0.6926 
3  0.6929 0.6928 0.6928 
4 25 µg/ml 0.6930 0.6926 0.6928 
5  0.6930 0.6927 0.6926 
6  0.6928 0.6927 0.6928 
Mean*  0.69293 0.6927167 0.692683 
SD**  0.00008 0.00007 0.000132916 
%RSD***  0.012 0.010 0.019 
* mean of six determinations ** standard deviation *** % relative standard deviation 
 
Table 7: Results of LOD and LOQ 
Active Ingredient LOD (µg/ml) LOQ (µg/ml) 
Tramadol Hydrochloride 2.412 7.308 
Aceclofenac 0.244 0.741 
 
Table 8: Robustness result of tramadol hydrochloride (variation parameter: wavelength±2 nm) 
S. No. Absorbance at 212.8 nm Absorbance at 216.8 nm 
1 0.3144 0.3148 
2 0.3143 0.3150 
3 0.3144 0.3149 
4 0.3143 0.3148 
5 0.3143 0.3149 
6 0.3145 0.3149 
Mean* 0.314367 0.314883 
SD** 0.00008 0.00007 
% RSD*** 0.025 0.022 
* mean of six determinations ** standard deviation *** % relative standard deviation 
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Table 9: Robustness result of aceclofenac (variation parameter: wavelength±2 nm) 
S. No. Absorbance at 273.6 nm Absorbance at 277.6 nm 
1 0.6925 0.6926 
2 0.6924 0.6924 
3 0.6924 0.6926 
4 0.6926 0.6925 
5 0.6925 0.6925 
6 0.6925 0.6924 
Mean* 0.692483 0.6925 
SD** 0.00007 0.00009 
% RSD*** 0.010 0.013 
* mean of six determinations ** standard deviation *** % relative standard deviation 
 
Table 10: Data of ruggedness of tramadol hydrochloride (9.4 µg/ml) and aceclofenac (25 µg/ml) 
S. No. Absorbance of tramadol hydrochloride at 214.8 nm Absorbance of aceclofenac at 275.6 nm 
Instrument 1 Instrument 2 Analyst 1 Analyst 2 Instrument 1 Instrument 2 Analyst 1 Analyst 2 
1 0.3148 0.3138 0.3148 0.3105 0.6930 0.7034 0.6975 0.7133 
2 0.3129 0.3008 0.3149 0.3148 0.6859 0.7231 0.6853 0.6936 
3 0.3128 0.3038 0.3108 0.3149 0.7034 0.6922 0.6911 0.6924 
4 0.3149 0.3048 0.3138 0.3148 0.6872 0.6877 0.7126 0.7140 
5 0.3048 0.3140 0.3148 0.3104 0.6918 0.7018 0.7002 0.7202 
6 0.3108 0.3114 0.3148 0.3128 0.6928 0.6935 0.6998 0.6951 
Mean * 0.3118 0.3081 0.3140 0.3130 0.6924 0.7003 0.6978 0.7048 
SD** 0.0038 0.0057 0.0016 0.0022 0.0062 0.0127 0.0093 0.0124 
%RSD*** 1.21 1.85 0.51 0.703 0.895 1.81 1.33 1.76 
* mean of six determinations ** standard deviation *** % relative standard deviation 
 
Table 11: Optical characteristics and validation parameters of tramadol hydrochloride and aceclofenac 
Parameters Results of tramadol hydrochloride Results of aceclofenac 
Detection wavelength 214.8 nm 275.6 nm 
Beer’s law limits 5–30 µg/ml 5–30 µg/ml 
Regression equation (y = mx+c) y = 0.026x+0.019 y = 0.027x–0.002 
Correlation coefficient (r2) 0.998 0.999 
Slope (m) 0.026 0.027 
Intercept (c) 0.019 0.002 
Intraday precision (% RSD) 0.025 0.0169 
Interday precision (% RSD) <2 <2 
Accuracy (% Recovery)   
80% 99.95% 98.01% 
100% 101.0% 98.36% 
120% 98.125% 98.17% 
LOD 2.412 µg/ml 0.244 µg/ml 
LOQ 7.308 µg/ml 0.741 µg/ml 
Robustness   
Wavelength (±2 nm) (% RSD) <2 <2 
Ruggedness (Using different instrument and different analyst) (% RSD) <2 <2 
 
The results obtained prove that the method is useful for 
simultaneous estimation of tramadol hydrochloride and aceclofenac 
in bulk and tablet dosage form. The developed method used very 
economical solvent and hence can be performed easily. 
Simultaneous estimation of the drugs can be achieved by various 
techniques like derivative spectroscopy or absorbance correction 
method, but simultaneous equation method was found to be easily 
performable for this combination of drugs as both the drug shows 
absorbance at each other’s wavelength of maximum absorbance. 
Estimation of tramadol hydrochloride and aceclofenac can thus be 
economically and simply done by simultaneous equation method. 
CONCLUSION 
The results indicate that the developed UV spectrophotometric 
method is simple, economical, precise and accurate. The developed 
method was found to be suitable for determination of tramadol 
hydrochloride and aceclofenac as a bulk drug and in marketed tablet 
dosage form without the interference of excipients. Statistical 
analysis proves that the method was repeatable. Hence, this method 
can be used for the simultaneous estimation of tramadol 
hydrochloride and aceclofenac in bulk and tablet dosage form. 
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